Arrowhead Research | ARWR - Deudores Comerciales





Deudores Comerciales Cambio Fecha
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 8.56M 7.13M 2026-06
Heron Therapeutics USD 89.59M 8.54M 2025-12
Incyte USD 1.13B 73.7M 2026-06
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
Ligand Pharmaceuticals USD 54.8M 6.25M 2026-03
Merck USD 12.21B 435M 2026-03
Moderna USD 17M 54M 2026-06
Nektar Therapeutics USD 3.6M 1.82M 2026-03
Novartis USD 9.85B 252M 2026-06
Sarepta Therapeutics USD 393.8M 154.11M 2026-06
TG Therapeutics USD 401.56M 9.52M 2026-06
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Vertex Pharmaceuticals USD 2.13B 138.2M 2026-06
Xencor USD 42.23M 30.23M 2026-06